Immunization for prevention of infective endocarditis

Current Infectious Disease Reports

Volumn 1, Issue 2, 1999, Pages 126-128

  Baddour, Larry M ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Capsular Polysaccharide; Endocarditis; Infective Endocarditis; Mitral Valve Prolapse; Passive Immunization

Indexed keywords

EID: 0001122153     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-996-0018-4     Document Type: Article

References (14)

1. Dajani AS, Taubert KA, Wilson W, et al.: Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997, 96:358–366.
2. Durack DT: Prophylaxis of infective endocarditis. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. New York: Churchill Livingstone; 1995:793–799.
3. Baddour LM, Bisno AL: Infective endocarditis complicating mitral valve prolapse: epidemiologic, clinical, and microbiologic aspects. Rev Infect Dis 1986, 8:117–137.
4. Scheld WM, Sande MA: Endocarditis and intravascular infections. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. New York: Churchill Livingstone; 1995:740–783.
5. Baddour LM, Sullam PM, Bayer AS: Pathogenesis of infective endocarditis. In Molecular Medical Microbiology. Edited by Sussman M. London: Academic Press; 1999:in press.
6. Baddour LM: Wound healing in the pathogenesis of experimental endocarditis. In Molecular Pathogenesis of Surgical Infections (Proceedings of an Eric K. Fernstrom Symposium). London: Springer-Verlag; 1992:377–393.
7. Balaban N, Goldkorn T, Nhan RT, et al.: Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 1998, 280:438–440. This investigation provides data that indicate that preexisting immunity in nonimmunized mice can impact disease severity.
8. Viscount HB, Munro CL, Burnette-Curley D, et al.: Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect Immun 1997, 65:994–1002. The work described in this study supports the notion that active immunization can protect animals against viridans group streptococcal experimental endocarditis.
9. Lee JC, Park J-S, Shepherd SE, et al.: Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 1997, 65:4146–4151. Experiments using a modified version of a rat model of experimental endocarditis showed that passive immunization can protect animals from developing endocardial infections due to S. aureus.
10. Schennings T, Heimdahl A, Coster K, Flock J-I: Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathogen 1993, 15:227–236.
11. Takeda S, Pier GB, Kojima Y, et al.: Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation 1991, 84:2539–2546.
12. Baddour, LM, Christensen GD, Lowrance JH, Simpson WA:Pathogenesis of experimental endocarditis. Rev Infect Dis 1989, 11:452–463.
13. Burnette-Curley D, Wells V, Viscount H, et al.: FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun 1995, 63:4669–4674.
14. Nemeth J, Lee JC: Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis. Infect Immun 1995, 63:375–380.